Aspen Pharmacre Hl ADR (APNHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 615,437 | 456,956 | 406,841 | 511,940 | 557,199 |
| Receivables | 788,585 | 792,360 | 830,067 | 828,815 | 696,858 |
| Inventories | 1,105,778 | 1,003,940 | 1,037,205 | 1,001,195 | 874,267 |
| Other current assets | 0 | 0 | 1 | 31,460 | 4,042 |
| TOTAL | $2,509,800 | $2,253,256 | $2,274,114 | $2,373,410 | $2,132,366 |
| Non-Current Assets | |||||
| PPE Net | 1,429,458 | N/A | 1,529,587 | N/A | 1,375,459 |
| Other Non-Current Assets | 3,998,027 | 3,625,601 | 3,986,823 | 4,219,475 | 4,026,294 |
| TOTAL | $5,427,485 | $3,625,601 | $5,516,410 | $4,219,475 | $5,401,753 |
| Total Assets | $7,573,618 | $6,848,717 | $7,328,475 | $7,627,230 | $7,151,397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 445,955 | 274,174 | 767,557 | 472,810 | 1,604,311 |
| Accounts payable and accrued liabilities | 574,152 | 612,020 | 661,948 | 631,670 | 600,688 |
| Other current liabilities | 234,680 | 30,786 | 69,551 | 105,885 | 191,166 |
| TOTAL | $1,305,547 | $940,608 | $1,539,391 | $1,210,365 | $2,396,165 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,205,550 | 1,247,839 | 696,296 | 1,294,280 | 17,343 |
| Other Non-Current Liabilities | 86,292 | 271,845 | 295,442 | 323,310 | 340,996 |
| TOTAL | $1,404,360 | $1,636,181 | $1,121,101 | $1,739,400 | $476,351 |
| Total Liabilities | $2,709,907 | $2,576,789 | $2,660,491 | $2,949,765 | $2,872,516 |
| Shareholders' Equity | |||||
| Common Shares | 94,132 | 94,742 | 117,387 | 123,240 | 122,250 |
| Retained earnings | 3,278,758 | N/A | 3,575,638 | N/A | 4,156,630 |
| Other shareholders' equity | 1,490,820 | 4,177,186 | 974,958 | 4,554,225 | 0 |
| TOTAL | $4,863,710 | $4,271,928 | $4,667,983 | $4,677,465 | $4,278,880 |
| Total Liabilities And Equity | $7,573,617 | $6,848,717 | $7,328,474 | $7,627,230 | $7,151,396 |